Photos: Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
Former hedge fund manager was under fire for buying a drug company and jacking the price of a lifesaving drug by 5,000%. He was charged today with securities fraud in a probe not directly related to the furor.
